STADA has continued to grow strongly during challenging times and, despite the difficult operating environment created by the coronavirus pandemic, which has reduced growth rates across most of the consumer health industry, the company doubled its revenue in 2020, following several acquisitions during the year. STADA’s recent rapid growth, with an aggressive acquisition strategy and ongoing brand awareness activities, creates optimism for the company’s performance in the coming years.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Euromonitor International's report on STADA Arzneimittel AG delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of STADA Arzneimittel AG, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of STADA Arzneimittel AG.
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page